-+ 0.00%
-+ 0.00%
-+ 0.00%

TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan

PUBT·06/18/2026 12:24:47
Listen to the news
TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan
  • Transthera Sciences (Nanjing) appointed Feng Weibo as an independent non-executive director, effective June 18, 2026, replacing Zheng Zhelan.
  • Feng also took over as chair of the remuneration and appraisal committee.
  • He joined the audit committee, joined the nomination committee.
  • Zheng stepped down as remuneration and appraisal committee chair, exited the audit committee, exited the nomination committee at the AGM’s close.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences (Nanjing) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260618-12208772), on June 18, 2026, and is solely responsible for the information contained therein.